Mycotic DNA in Non-Atherosclerotic Aortic Wall of Coronary Patients Is Associated With sICAM-1 Expression

Identification of Coronary Atherosclerotic Lesions in Rat Induced by Intravenous Candida Albicans

“…The results showed that there was an effect of C. albicans infection that was injected intravenously to the formation of coronary atherosclerosis lesion seen from three parameters, i.e., coronary artery wall thickness, the presence of cap coronary artery, and foam cell in coronary artery wall. The results of this study are supported by previous epidemiological studies that prove that fungal infection of C. albicans is associated with an increased risk of developing cardiovascular disease [10][11]16]. Jegier et al explained that there is DNA C. albicans in 58% of samples of patients with coronary heart disease identified by the PCR method [10].…”

“…The results of this study are supported by previous epidemiological studies that prove that fungal infection of C. albicans is associated with an increased risk of developing cardiovascular disease [10][11]16]. Jegier et al explained that there is DNA C. albicans in 58% of samples of patients with coronary heart disease identified by the PCR method [10].…”

“…Opportunistic pathogen Candida is a species that can cause infections in the superficial mucosa to spread to the blood vessels, causing injury to the endothelium and stimulates autoimmune [9]. This research shows that there is a connection between candida infections with lesions of atherosclerosis that is supported by the results of research which states that there is DNA of C. albicans in 58% of coronary heart disease patient samples identified by the method of polymerase chain reaction (PCR) [10]. 67.7% of patients with stenosis the coronary artery have a Candida colony in its oral cavity [11].…”